MTB
63
-2
NOV
58
3
NAVI
41
-3
STI
47
-12
PSA
51
-4
PEP
41
6
JNJ
41
2
AXP
66
2
TRV
53
-3
AKAM
43
3
DAL
80
-4
EL
20
3
AIV
68
-4
FMC
31
5
WMT
74
2
CVX
46
5
MDLZ
34
2
KMX
58
3
CINF
47
2
CF
59
3
MTB
63
-2
NOV
58
3
NAVI
41
-3
STI
47
-12
PSA
51
-4
PEP
41
6
JNJ
41
2
AXP
66
2
TRV
53
-3
AKAM
43
3
DAL
80
-4
EL
20
3
AIV
68
-4
FMC
31
5
WMT
74
2
CVX
46
5
MDLZ
34
2
KMX
58
3
CINF
47
2
CF
59
3
Financhill
Back

Iterum Therapeutics PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
75

ITRM
Iterum Therapeutics PLC

Last Price:
1.77
Seasonality Move:
65.6%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Iterum Therapeutics PLC Price Quote

$1.77
+0.14 (+8.59%)
(Updated: November 21, 2024 at 5:55 PM ET)

Iterum Therapeutics PLC Key Stats

Buy
75
Iterum Therapeutics PLC (ITRM) is a Buy
Day range:
$1.52 - $1.65
52-week range:
$0.81 - $2.50
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
27.11
P/B ratio:
0%
Volume:
1M
Avg. volume:
4.9M
1-year change:
18.12%
Market cap:
$23.5M
Revenue:
$0
EPS:
$-2.65

How Much Does Iterum Therapeutics PLC Make?

Data Unavailable

Is Iterum Therapeutics PLC Growing As A Company?

Data Unavailable

Iterum Therapeutics PLC Stock Price Performance

What Is Iterum Therapeutics PLC 52-Week High & Low?

Iterum Therapeutics PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Iterum Therapeutics PLC?

Is Iterum Therapeutics PLC Cash Flow Positive?

  • What Is ITRM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$42.8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $8M
  • What Is Iterum Therapeutics PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $25.4M

Iterum Therapeutics PLC Return On Invested Capital

Data Unavailable

Iterum Therapeutics PLC Earnings Date & Stock Price

Iterum Therapeutics PLC Competitors

Iterum Therapeutics PLC Dividend Yield

Iterum Therapeutics PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -14.29%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 7.50
Upside from Last Price: 360.12%

Major Shareholders

  • How many ITRM shares are owned by institutional investors?
    668.4K ITRM shares are owned by institutional investors
  • How many ITRM shares are owned by insiders?
    511.1K ITRM shares are owned by insiders